U.S. FDA
panel backs Valeant psoriasis drug with risk management
July 19 (Reuters) -
Valeant Pharmaceuticals InternationalInc's experimental
drug to treat the skin disorderpsoriasis should be approved as long as certain measures are putin place to mitigate the...